Biotech news

Latest breaking stories, features and analysis

Regeneron Pharmaceuticals’ profit comes in better than expected in Q4
  • Regeneron Pharmaceuticals’ profit comes in better than expected in Q4.
  • The biotech firm's revenue matches expectations in the fourth quarter.
  • Italy authorises conditional use of Regeneron’s COVID-19 antibody therapies.
February 5, 2021

More breaking stories